Literary study of Veshtan Chikitsa from 3 main Ayurvedic Samhitas along with the role of covering of head,forehead and ear region in patients of rhinitis

Literary study of Veshtan Chikitsa from Bruhatrayi with the role of Shiropariveshtan as Viharaj Chikitsa in patients of Pratishyay

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021365

Enrollment

120

Registered

2019-09-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Vyoshadi vati and Shiropariveshtan: Vyoshadi vati dose-500mg after both the meals Administration route-Oral Duration-5 days. Shiropariveshtan at night time, while travelling, while exp

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age group-20yr.-60yr. 2)Patients of either gender. 3)Patients presenting any 4 symptoms as main symptom among following- kshavathu, nasa avarodh, atitrushna, shirashoola, gala-talu-oshtha shosh

Exclusion criteria

Exclusion criteria: 1)Patients having nasal deformities like DNS,etc. 2)Patients with comorbidity like DM, HTN, malignancy,etc. 3)Patients with any surgical procedures done around or on nasal area and nose. 4)Injury due to fall on face, injuries due to accidents. 5)Patients having Pratishyay as a symptom or complication of any disease or complication of any surgical procedure.

Design outcomes

Primary

Measure	Time frame
The primary outcome will be significant effect of Shiropariveshtan in patients of Pratishyay.Timepoint: 3 to 4 days.	—

Secondary

Measure	Time frame
Symptoms of Pratishyay will be reduced.Timepoint: 5-7 days	—

Countries

India

Contacts

Public ContactDr Hemangi Vasudeo Shendye

Bharati Vidyapeeth College of Ayurved, Pune-Satara Road, Pune 411043

cureforsure@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026